Ameriprise’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $480K | Buy |
42,186
+11,500
| +37% | +$131K | ﹤0.01% | 3513 |
|
|
2025
Q1 | $365K | Sell |
30,686
-1,466
| -5% | -$17.4K | ﹤0.01% | 3581 |
|
|
2024
Q4 | $606K | Buy |
32,152
+16,921
| +111% | +$319K | ﹤0.01% | 3424 |
|
|
2024
Q3 | $342K | Sell |
15,231
-31,573
| -67% | -$709K | ﹤0.01% | 3592 |
|
|
2024
Q2 | $977K | Sell |
46,804
-59,060
| -56% | -$1.23M | ﹤0.01% | 3169 |
|
|
2024
Q1 | $1.56M | Sell |
105,864
-4,848
| -4% | -$71.3K | ﹤0.01% | 2986 |
|
|
2023
Q4 | $1.14M | Buy |
110,712
+50,394
| +84% | +$520K | ﹤0.01% | 3132 |
|
|
2023
Q3 | $474K | Buy |
+60,318
| New | +$474K | ﹤0.01% | 3433 |
|
|
2023
Q2 | – | Sell |
-40,649
| Closed | -$361K | – | 3971 |
|
|
2023
Q1 | $361K | Buy |
40,649
+17,949
| +79% | +$159K | ﹤0.01% | 3543 |
|
|
2022
Q4 | $249K | Buy |
+22,700
| New | +$249K | ﹤0.01% | 3652 |
|
|
2021
Q3 | – | Sell |
-224,686
| Closed | -$5.96M | – | 3912 |
|
|
2021
Q2 | $5.96M | Buy |
224,686
+5,065
| +2% | +$134K | ﹤0.01% | 2328 |
|
|
2021
Q1 | $6.83M | Buy |
219,621
+90,821
| +71% | +$2.82M | ﹤0.01% | 2182 |
|
|
2020
Q4 | $4.24M | Sell |
128,800
-126,448
| -50% | -$4.16M | ﹤0.01% | 2382 |
|
|
2020
Q3 | $8.91M | Buy |
+255,248
| New | +$8.91M | ﹤0.01% | 1637 |
|